HSBC Holdings’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.7M | Sell |
25,900
-27,600
| -52% | -$28M | 0.01% | 696 |
|
|
2025
Q4 | $57.7M | Buy |
+53,500
| New | +$51.2M | 0.03% | 455 |
|
|
2025
Q3 | – | Sell |
-1,200
| Closed | -$932K | – | 2961 |
|
|
2025
Q2 | $932K | Sell |
1,200
-48,800
| -98% | -$37.9M | ﹤0.01% | 1839 |
|
|
2025
Q1 | $40.5M | Buy |
50,000
+43,800
| +706% | +$36.4M | 0.03% | 530 |
|
|
2024
Q4 | $4.78M | Sell |
6,200
-8,500
| -58% | -$7.04M | ﹤0.01% | 1151 |
|
|
2024
Q3 | $12.9M | Sell |
14,700
-27,100
| -65% | -$24.4M | 0.01% | 845 |
|
|
2024
Q2 | $38.1M | Sell |
41,800
-5,700
| -12% | -$4.56M | 0.02% | 519 |
|
|
2024
Q1 | $37M | Buy |
47,500
+9,200
| +24% | +$6.55M | 0.03% | 541 |
|
|
2023
Q4 | $22.3M | Buy |
38,300
+38,142
| +24,141% | +$22.3M | 0.02% | 637 |
|
|
2023
Q3 | $84.9K | Buy |
+158
| New | +$81.4K | ﹤0.01% | 2573 |
|
|
2022
Q1 | – | Sell |
-47,100
| Closed | -$13.1M | – | 3384 |
|
|
2021
Q4 | $13.1M | Buy |
47,100
+42,700
| +970% | +$10.8M | 0.01% | 840 |
|
|
2021
Q3 | $1.02M | Sell |
4,400
-28,400
| -87% | -$7.01M | ﹤0.01% | 1870 |
|
|
2021
Q2 | $7.54M | Sell |
32,800
-6,500
| -17% | -$1.31M | 0.01% | 958 |
|
|
2021
Q1 | $7.37M | Sell |
39,300
-14,600
| -27% | -$2.86M | 0.01% | 890 |
|
|
2020
Q4 | $9.02M | Buy |
53,900
+1,200
| +2% | +$179K | 0.01% | 820 |
|
|
2020
Q3 | $7.8M | Sell |
52,700
-14,800
| -22% | -$2.29M | 0.01% | 792 |
|
|
2020
Q2 | $11.1M | Buy |
+67,500
| New | +$10.4M | 0.02% | 617 |
|
|
2019
Q4 | – | Sell |
-3,600
| Closed | -$403K | – | 3128 |
|
|
2019
Q3 | $403K | Hold |
3,600
| – | – | ﹤0.01% | 2449 |
|
|
2019
Q2 | $399K | Sell |
3,600
-66,600
| -95% | -$7.84M | ﹤0.01% | 2176 |
|
|
2019
Q1 | $9.11M | Sell |
70,200
-206,900
| -75% | -$25.2M | 0.02% | 854 |
|
|
2018
Q4 | $32.1M | Buy |
277,100
+29,200
| +12% | +$3.26M | 0.06% | 329 |
|
|
2018
Q3 | $26.6M | Sell |
247,900
-47,700
| -16% | -$4.77M | 0.04% | 442 |
|
|
2018
Q2 | $25.2M | Buy |
295,600
+10,800
| +4% | +$887K | 0.04% | 415 |
|
|
2018
Q1 | $22M | Buy |
284,800
+282,800
| +14,140% | +$22.8M | 0.03% | 504 |
|
|
2017
Q4 | $169K | Sell |
2,000
-322,300
| -99% | -$27.4M | ﹤0.01% | 1952 |
|
|
2017
Q3 | $27.7M | Buy |
324,300
+52,000
| +19% | +$4.26M | 0.04% | 422 |
|
|
2017
Q2 | $22.4M | Buy |
272,300
+94,300
| +53% | +$7.69M | 0.04% | 466 |
|
|
2017
Q1 | $15M | Sell |
178,000
-157,600
| -47% | -$12.6M | 0.03% | 560 |
|
|
2016
Q4 | $24.7M | Sell |
335,600
-99,300
| -23% | -$7.4M | 0.06% | 403 |
|
|
2016
Q3 | $34.9M | Buy |
434,900
+93,900
| +28% | +$7.52M | 0.09% | 261 |
|
|
2016
Q2 | $26.9M | Buy |
341,000
+101,100
| +42% | +$7.61M | 0.07% | 319 |
|
|
2016
Q1 | $17.3M | Buy |
239,900
+19,900
| +9% | +$1.51M | 0.05% | 462 |
|
|
2015
Q4 | $18.5M | Buy |
+220,000
| New | +$18.3M | 0.04% | 477 |
|
|
2015
Q3 | – | Sell |
-624,913
| Closed | -$52.2M | – | 2067 |
|
|
2015
Q2 | $52.2M | Buy |
+624,913
| New | +$47.6M | 0.11% | 205 |
|
|
2015
Q1 | – | Sell |
-180,000
| Closed | -$12.4M | – | 2094 |
|
|
2014
Q4 | $12.4M | Hold |
180,000
| – | – | 0.03% | 596 |
|
|
2014
Q3 | $11.7M | Hold |
180,000
| – | – | 0.02% | 600 |
|
|
2014
Q2 | $11.2M | Hold |
180,000
| – | – | 0.02% | 578 |
|
|
2014
Q1 | $10.6M | Sell |
180,000
-393,900
| -69% | -$22M | 0.03% | 547 |
|
|
2013
Q4 | $29.3M | Buy |
573,900
+150,800
| +36% | +$7.55M | 0.08% | 292 |
|
|
2013
Q3 | $21.3M | Buy |
+423,100
| New | +$22.2M | 0.06% | 372 |
|
Other funds holding LLY
VCM
VPM
HSBC Holdings's LLY Position: Q1 2026 in Review
HSBC Holdings reduced its Eli Lilly (LLY) stake by 6% in Q1 2026, selling an estimated $121M and leaving 1,865,688 shares worth $1.71B. The position accounts for 0.9% of the portfolio, ranked #14.
HSBC Holdings first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.13B in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- HSBC Holdings held 1,865,688 shares of Eli Lilly worth $1.71B as of Q1 2026.
- HSBC Holdings sold 118,868 Eli Lilly shares in Q1 2026, an estimated $121M.
- Eli Lilly made up 0.9% of HSBC Holdings's portfolio in Q1 2026, its #14 holding.
- HSBC Holdings first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- HSBC Holdings's Eli Lilly position peaked at $2.13B in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.